Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Translating Neurogenomics into New Medicines.
[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs].
The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.
MRI outcomes in the diagnosis and disease course of multiple sclerosis.
SNPsea: an algorithm to identify cell types, tissues, and pathways affected by risk loci.
Objective assessment of C-fiber function by electrically induced axon reflex flare in patients with axonal and demyelinating polyneuropathy.
Fatty fish intake is associated with decreased occurrence of multiple sclerosis.
[Targeted Therapy and Progressive Multifocal Leukoencephalopathy (PML): PML in the Era of Monoclonal Antibody Therapies].
Serum vitamin d levels in Indian patients with multiple sclerosis.
Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus Macaques.
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.
Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study.
Quantifying Demyelination in NK venom treated nerve using its electric circuit model.
Correction to: The role of MRI in the evaluation of secondary progressive multiple sclerosis.
Anti-CCP Antibody Levels Are Not Associated with MS: Results from a Case-Control Study.
Exogenous Adult Post Mortem Neural Precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury.
Autoimmune Hepatitis with Multiple Sclerosis and Graves Disease: Coincidence or Association?
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
Brain functional plasticity at rest and during action in multiple sclerosis patients.
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
Comment on: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'
The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
[Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome].
Pages
« first
‹ previous
…
648
649
650
651
652
653
654
655
656
…
next ›
last »